<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03393988</url>
  </required_header>
  <id_info>
    <org_study_id>FMASU R45/2017</org_study_id>
    <nct_id>NCT03393988</nct_id>
  </id_info>
  <brief_title>Techniques for Perioperative Analgesia for Live Liver Donors; A Pilot Study</brief_title>
  <official_title>A Pilot Study for a Prospective, Randomized Controlled Trial of Techniques for Perioperative Analgesia for Live Liver Donors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study,will evaluate the efficacy of ultrasound (US)-guided subcostal oblique TAP block
      together with IV infusion of Dexmedetomidine and fentanyl as a type of multimodal analgesic
      regimen in comparison with IV fentanyl based analgesia only in live liver donors.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 7, 2017</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total fentanyl consumption</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Total Intravenous fentanyl consumption during the operation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Average sevoflurane concentration</measure>
    <time_frame>Intraoperative</time_frame>
    <description>The average sevoflurane concentration (the average concentration (%) for the case will be determined from the vaporizer setting recorded in the anesthetic record per 5-minute interval)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The severity of postoperative nausea and vomiting (PONV)</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Will be recorded and classified as &quot;no PONV, mild PONV, moderate PONV and severe PONV&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ramsay sedation score (RSS)</measure>
    <time_frame>First 24 hours postoperatively</time_frame>
    <description>Will be used for assessment of sedation immediately after extubation, after 2 hours of ICU admission, after 12 hours then after 24 hours .</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Anesthesia</condition>
  <arm_group>
    <arm_group_label>Group F</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fentanyl infusion (0.5 µg/kg/hr)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group (TAP-Dex)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ultrasound guided TAP block and Dexmedetomidine
Ultrasound guided subcostal oblique TAP block with 0.25 % bupivacaine
Dexmedetomidine infusion(200 µg in 2 ml diluted in 48 ml of saline)
Fentanyl infusion (0.5 µg/kg/hr).</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fentanyl infusion</intervention_name>
    <description>After induction of general anesthesia; Fentanyl infusion (0.5 µg/kg/hr) will be started (which will be afterwards adjusted intraoperatively according to the hemodynamics and Bispectral Index (BIS) reading).</description>
    <arm_group_label>Group F</arm_group_label>
    <arm_group_label>Group (TAP-Dex)</arm_group_label>
    <other_name>Opioid</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound guided TAP block</intervention_name>
    <description>After induction of general anesthesia; Patients will receive ultrasound guided subcostal oblique TAP block with 0.25 % bupivacaine 40 ml on each side resulting in a total volume of 80 ml, subcostal TAP block was given twice, at the beginning and at the end of the surgery.</description>
    <arm_group_label>Group (TAP-Dex)</arm_group_label>
    <other_name>Regional anesthesia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine (200 µg in 2 ml diluted in 48 ml of saline) will be started in a dose of 1 μg/kg over 10 min then maintenance dose as continuous infusion between 0.2 and 0.8 μg/ kg/h through infusion pump (which will be adjusted according to the hemodynamics and BIS reading)</description>
    <arm_group_label>Group (TAP-Dex)</arm_group_label>
    <other_name>alpha 2 sympathomimetic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesia (ASA) physical status I or II

          -  Scheduled as live liver donors

          -  J-shaped incision in the supraumblical region

        Exclusion Criteria:

          -  Patients with a history of psychiatric/neurological illness,

          -  Hypertensive patients,

          -  Morbidly obese patients,

          -  Pregnant and nursing women,

          -  Patients with known allergic reaction to any of the study medications,

          -  Patients on recent use of sedatives or analgesics,

          -  Patients with significant laboratory abnormalities
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospitals of Faculty of Medicine , Ain Shams University</name>
      <address>
        <city>Cairo</city>
        <zip>11591</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 23, 2017</study_first_submitted>
  <study_first_submitted_qc>January 8, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2018</study_first_posted>
  <last_update_submitted>January 8, 2018</last_update_submitted>
  <last_update_submitted_qc>January 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Rasha Samir Abd-ElWahab Bondok</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Transversus abdominis plane block,</keyword>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Fentanyl</keyword>
  <keyword>Live liver donor</keyword>
  <keyword>Liver transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Fentanyl</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Sympathomimetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

